Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Cardinal Health, Inc’s stock clocked out at $198.83, down -0.18% from its previous closing price of $199.19. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 1.74 million shares were traded. CAH stock price reached its highest trading level at $200.255 during the session, while it also had its lowest trading level at $198.1.
Ratios:
To gain a deeper understanding of CAH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.61. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.96.
On February 05, 2025, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $140 to $150.
TD Cowen Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $130 to $144.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 20 ’25 when WEITZMAN DEBORAH bought 21,367 shares for $150.53 per share.
WEITZMAN DEBORAH sold 21,367 shares of CAH for $3,216,375 on Aug 20 ’25. The CEO, PSS Segment now owns 53,428 shares after completing the transaction at $150.53 per share. On Aug 20 ’25, another insider, Hollar Jason M., who serves as the Chief Executive Officer of the company, sold 35,901 shares for $150.04 each. As a result, the insider received 5,386,566 and left with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 47241023488 and an Enterprise Value of 51828023296. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.01, and their Forward P/E ratio for the next fiscal year is 17.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20. Its current Enterprise Value per Revenue stands at 0.221 whereas that against EBITDA is 14.624.
Stock Price History:
The Beta on a monthly basis for CAH is 0.66, which has changed by 0.6353841 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, CAH has reached a high of $214.93, while it has fallen to a 52-week low of $114.60. The 50-Day Moving Average of the stock is 9.60%, while the 200-Day Moving Average is calculated to be 27.48%.
Shares Statistics:
It appears that CAH traded 2.49M shares on average per day over the past three months and 2566390 shares per day over the past ten days. A total of 238.00M shares are outstanding, with a floating share count of 237.00M. Insiders hold about 0.26% of the company’s shares, while institutions hold 90.31% stake in the company. Shares short for CAH as of 1763078400 were 8047562 with a Short Ratio of 3.23, compared to 1760486400 on 6612284. Therefore, it implies a Short% of Shares Outstanding of 8047562 and a Short% of Float of 3.9.
Dividends & Splits
With its trailing 12-month dividend rate of 2.033, CAH has a forward annual dividend rate of 2.03. Against a Trailing Annual Dividend Yield of 0.010206335. The stock’s 5-year Average Dividend Yield is 2.5. The current Payout Ratio is 31.43% for CAH, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2001-04-23 when the company split stock in a 3:2 ratio.
Earnings Estimates
The firm’s stock currently is rated by 14.0 analysts. The consensus estimate for the next quarter is $2.69, with high estimates of $2.93 and low estimates of $2.52.
Analysts are recommending an EPS of between $10.18 and $9.74 for the fiscal current year, implying an average EPS of $9.83. EPS for the following year is $11.07, with 15.0 analysts recommending between $11.44 and $10.82.
Revenue Estimates
In. The current quarter, 13 analysts expect revenue to total $64.88B. It ranges from a high estimate of $66.24B to a low estimate of $63.97B. As of. The current estimate, Cardinal Health, Inc’s year-ago sales were $55.26BFor the next quarter, 13 analysts are estimating revenue of $62.77B. There is a high estimate of $64.49B for the next quarter, whereas the lowest estimate is $60.67B.
A total of 14 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $263.87B, while the lowest revenue estimate was $255.37B, resulting in an average revenue estimate of $258.34B. In the same quarter a year ago, actual revenue was $222.58BBased on 14 analysts’ estimates, the company’s revenue will be $279.86B in the next fiscal year. The high estimate is $290.02B and the low estimate is $269.22B.
